MG

Mahiboob Gulamhusen Mujawar

Director Director DIN 10496939
DIN 10496939 First appointment Feb 2024 Primary industry Consumer Durables
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahiboob Gulamhusen Mujawar

Data last updated:

Mahiboob Gulamhusen Mujawar was a Director at Meditek Lifecare Limited (2024) and Designated Partner at Meditek Lifecare Llp (from 2024). The companies operate in Consumer Durables.

DIN 10496939
Primary Designation Director
Industry Consumer Durables
First Appointment 05 Feb 2024
Oldest Company Age 8 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meditek Lifecare Limited U43222MH2024PLC424467
Director30 Apr 20242024Active
Designated Partner05 Feb 20242017Converted And Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Meditek Lifecare Llp
Meditek Lifecare Limited
Premium access

Shareholding and investment profile for Mahiboob Gulamhusen Mujawar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahiboob Gulamhusen Mujawar

Mahiboob Gulamhusen Mujawar was first appointed on 05 Feb 2024 as Designated Partner at Meditek Lifecare Llp.

Mahiboob Gulamhusen Mujawar held 2 earlier board appointments: Meditek Lifecare Limited (Director, 30 Apr 2024 to 07 Oct 2024); Meditek Lifecare Llp (Designated Partner, from 05 Feb 2024).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available